MEDS (MEDS) financials · rev $23.3M
MEDS (MEDS) rev $23.3M.
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $23.3M | $18.1M | $0 |
| Cost of Revenue | $29.8M | $16.4M | $0 |
| Gross Profit | -$6.4M | $1.8M | $0 |
| Operating Income | -$93.7M | -$6.1M | -$2.9M |
| Net Income | -$101.3M | -$6.9M | -$2.9M |
| EPS (Diluted) | $-1.43 | $-0.15 | $-0.06 |
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Total Assets | $30.5M | $57.3M | $338.4K |
| Current Assets | $2.8M | $15.2M | $338.4K |
| Cash & Equivalents | $42.6K | $1.0M | $1.4K |
| Inventory | $1.6M | $9.5M | $0 |
| PP&E | $229.4K | $388.2K | $0 |
| Total Liabilities | $42.9M | $50.6M | $3.2M |
| Current Liabilities | $29.8M | $38.0M | $2.9M |
| Short-term Debt | $10.9M | $11.9M | $350.0K |
| Long-term Debt | $12.6M | $11.5M | $0 |
| Total Debt | $0 | $0 | $0 |
| Shareholders' Equity | -$12.4M | $6.7M | -$2.9M |
| Retained Earnings | -$111.0M | -$9.8M | -$2.9M |
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Operating Cash Flow | -$10.9M | -$1.2M | -$349.1K |
| CapEx | $0 | $0 | $0 |
| Investing Cash Flow | -$881.5K | $469.1K | $0 |
| Financing Cash Flow | $10.8M | $1.8M | $350.5K |
| Dividends Paid | $0 | $0 | $0 |
| Net Change in Cash | -$985.8K | $1.0M | $1.4K |
| Free Cash Flow | $0 | $0 | $0 |
FAQ
What is MEDS P/E and revenue?
MEDS (MEDS) rev $23.3M.
What is MEDS revenue?
MEDS last cached revenue is $23.3M (FY2025).
Is MEDS profitable?
MEDS last cached net income is -$101.3M.
What are MEDS total assets?
MEDS last cached total assets are $30.5M.
What is MEDS free cash flow?
MEDS last cached free cash flow is $0.
Not investment advice. Cached statements, not a live tape.